ACE Insights (Archived)
Explore ACE's e-bulletins showcasing Singapore's healthcare initiatives, from treatment subsidies to clinical guidelines and patient success stories.
Last updated 1 July 2026
ACE Insights e-bulletin Issue Eleven
Discover how ACE's work advances healthcare solutions that deliver value today and tomorrow.
Key highlights:
Enhanced access to care for severe Mitral Regurgitation with transcatheter procedure: How transcatheter mitral valve leaflet repair (TMVLR) helps patients with severe mitral regurgitation.
ACE celebrates its 10th Anniversary: Milestones from ACE's first decade in advancing Appropriate and Value-Based Care.
Meet a Principal Analyst from ACE's Health Technology Adoption and Education Team, who is driving patient access to clinically and cost-effective healthcare.
ACE Insights e-bulletin Issue Ten
Discover how evidence-based healthcare and accessible treatments are making a real difference.
Key highlights:
Haemophilia drug subsidy brings hope to patients: learn about a young patient's journey to better health through subsidised treatment.
A look at how ACE is shaping the future of value-based healthcare through global and local partnerships.
Meet a specialist from ACE's Evidence to Practice Office, who is bridging the gap between research and clinical practice.
ACE Insights e-bulletin Issue Nine
Local and international delegates gathered at the ACE Value-Based Healthcare Conference 2024 in Singapore to share best practices for better patient outcomes.
Key highlights:
A recent funding recommendation for tafamidis enhances affordability and treatment options for patients with transthyretin amyloid cardiomyopathy.
A Specialist from the Medical Technology Evaluation team shares why his work is rewarding and impactful.
ACE Insights e-bulletin Issue Eight
Learn how the Implant Subsidy List (ISL) enables patient access to a range of subsidised implants.
Key highlights:
New clinical guidelines for hypertension and hyperlipidaemia supporting healthcare professionals in their efforts to address these increasingly prevalent conditions.
CGM systems are now subsidised, making them more affordable for children and adults with type 1 diabetes.
Discover how ACE’s work has helped patients with COPD access treatment that is better for them and better for the healthcare system.
ACE Insights e-bulletin Issue Seven
Read about the available T2DM resources that can guide healthcare professionals and help patients in managing this condition.
Key highlights:
The ACE Consumer Panel Co-Chairs share how greater patient involvement in healthcare decision-making can positively impact patients in Singapore.
An erythropoiesis-stimulating agent found on the Ministry of Health’s List of Subsidised Drugs helped to alleviate the persistent symptoms of anaemia in a patient with chronic kidney disease.
ACE Insights e-bulletin Issue Six
Read about the value-based initiatives implemented across Singapore’s healthcare system that have led to improved clinical outcomes and cost savings.
Key highlights:
Hear from a Senior Specialist in our Consumer Engagement and Education department, who shares how she empowers patients to make informed decisions
A targeted therapy subsidised under the Cancer Drug List improves accessibility and affordability of treatment for a patient suffering from a rare blood cancer
ACE Insights e-bulletin Issue Five
A dive into patient empowerment and involvement, and how ACE’s resources have supported healthcare professionals.
Key highlights:
How ACE’s new Consumer Engagement and Education workstream involves patients and patient organisations in ACE’s work
An elderly patient and his clinician discuss the benefits of the TAVI implant for treating severe aortic stenosis
A retrospective analysis of the real-world impact of NON-Vitamin K Antagonist ORAL Anticoagulants (NOACs) (opens in new tab) on patient outcomes in Singapore
ACE Insights e-bulletin Issue Four
Featuring ACE's Horizon Scanning and treatment subsidies for two chronic conditions.
Key highlights:
Two patients suffering from chronic conditions experience relief with subsidies for their long-term treatments
A retrospective analysis of the real-world impact of SGLT2 inhibitors (opens in new tab) on patient outcomes in Singapore
Join our inaugural Value-Based Healthcare Conference coming September 2022
ACE Insights e-bulletin Issue Three
Featuring acupuncture subsidy and ACE CUES.
Key highlights:
Three human interest stories featuring an acupuncturist and two patients and their experience with acupuncture subsidy
Positive testimonials from healthcare professionals regarding the use of ACGs (ACE Clinical Guidances) and ACE CUES
Look out for soon to be released ACE Webinars on our Video Resources page
ACE Insights e-bulletin Issue Two
Showcasing positive testimonies and impact of ACE's work.
Key highlights:
Antiretroviral therapies for persons living with HIV are now available for mainstream subsidy
Three human interest stories featuring healthcare professionals and patients/caregiver who have benefitted from treatments and subsidies informed by ACE's evaluations and value-based negotiations
Watch ACE's video on how subsidy of hepatitis C medicines has made a positive impact
ACE's inaugural e-bulletin commemorating ACE's 5th anniversary
Key highlights:
Thank you note from A/Prof Kenneth Mak, Director of Medical Services
Update of our recently published drug and medical technology guidances
Launch of ACE Clinical Update Service (ACE CUES)
